Severe COVID-19 Infections—Knowledge Gained and Remaining Questions

Type Journal Article Author Lieuwe D. J. Bos Author Daniel Brodie Author Carolyn S. Calfee URL https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2770931 Publication Jama Network | Internal Medcine Date 18/09/2020 DOI doi:10.1001/jamainternmed.2020.6047 Language en Abstract Patients with acute respiratory failure due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have overwhelmed critical care capacity in some cities and countries. The mortality of patients who require critical care is high but varies widely among hospitals.1 Despite a rapidly increasing understanding of the pathogenesis of coronavirus disease 2019 (COVID-19), uncertainty remains about the reasons that some patients develop respiratory failure and others have no to minimal symptoms, as well as about the optimal management of patients with severe COVID-19 disease.2 We review the evidence for the management of patients with the acute respiratory distress syndrome (ARDS) that may apply to patients with severe COVID-19, what has been learned about treatment of these patients, and the gaps in knowledge that remain.